Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7 publications
Once-daily mesalamine granules for maintaining remission of ulcerative colitis: pooled analysis of efficacy, safety, and prognostic factors.
Journal: Postgraduate medicine
Published: February 11, 2016
Once-daily Mesalamine Formulation for Maintenance of Remission in Ulcerative Colitis: A Randomized, Placebo-controlled Clinical Trial.
Journal: Journal of clinical gastroenterology
Published: September 15, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trial.
Journal: Inflammatory bowel diseases
Published: May 20, 2015
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis.
Journal: Digestive diseases and sciences
Published: April 27, 2015
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.
Journal: Digestive diseases and sciences
Published: April 11, 2015
Mesalazine granules 1.5 g once-daily maintain remission in patients with ulcerative colitis who switch from other 5-ASA formulations: a pooled analysis from two randomised controlled trials.
Journal: Alimentary pharmacology & therapeutics
Published: December 19, 2011
Showing 1-7 of 7
Last Updated: 09/26/2026